Trump clears path for expanded psychedelic research to treat veterans’ PTSD
The order commits at least $50 million in federal funds to boost research on ibogaine, a powerful hallucinogen.
By Tanya Noury
Latest ""
He hunted roadside bombs in Iraq. Now he hunts adventure to combat PTSD.
Veteran retreats taught him how to kayak, ski and forgive himself.
By Casey Elliott, The War Horse
VA mental health providers say they are under pressure to limit care
Veterans Affairs officials insist there are no caps on mental health care, but providers in multiple states disagree.
By Leah Rosenbaum, The War Horse
Will RFK Jr.’s push for psychedelics help or hurt the emerging field?
Veterans groups are among those seeking to access the drug ibogaine and other psychedelics to treat PTSD, opioid addiction and other conditions.
By Matthew Perrone
‘My Dead Friend Zoe’ is a veteran’s ghost story that refuses to fade
Authenticity is the film’s greatest strength. It doesn’t lean on clichés. Instead, it sits with discomfort — awkward, hilarious and harrowing.
By Clay Beyersdorfer
Meet the kids taking care of wounded veterans
More than 2 million kids live with a disabled veteran at home. Calls are growing to extend more support to these ‘hidden helpers.'
By Jennifer Brookland, The War Horse
DOD commits $9.8 million to study psychedelics for active-duty troops
During one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to active-duty soldiers with mild to moderate PTSD.
By Noah Daly
40% rise in mental health diagnoses among troops, report finds
Diagnoses of PTSD and anxiety disorders nearly doubled between 2019 and 2023, according to a new Defense Health Agency report.
By Riley Ceder
Psychedelic therapy sparks clash between Colorado officials and vets
Amid psychedelic therapy's legalization in Colorado, veterans implored Colorado Springs officials not to pass treatment restrictions.
VA awards $1.5 million to study using psychedelics for PTSD treatment
The move is the first time Veterans Affairs leaders have funded a study into psychedelic benefits since the 1960s.
Combat tours don’t cause permanent readjustment issues for vets: Study
A 20-year study of more than 2,000 Swedish service members found no long-term obstacles to them finding work and succeeding after serving in war zones.
FDA rejects psychedelic MDMA as treatment for PTSD
MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.
By Matthew Perrone